Long-Term Effects of Goshajinkigan in Prevention of Diabetic Complications: A Randomized Open-Labeled Clinical Trial
Figure 2
Primary endpoint. A total of 43 participants had a microvascular event and no macrovascular events: 40.2% in the goshajinkigan group and 39.1% in the control group (). The mean duration of follow-up was 28 months for the goshajinkigan group and 15 months for the control.
